Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 1/20 | 0.34 |
| ▸ | XPO1 | O14980 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 3/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA7 | P43166 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | MET | P08581 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24802620 | 0.80 | RARA (0.34) | — | |
| SCHEMBL29186827 | 0.74 | OPRM1 (0.34) | OPRM1XPO1MEN1KMT2AALDH1A1 | |
| SCHEMBL30051346 | 0.73 | ATM (0.39) | OPRM1MEN1KMT2APOLBSMN1; SMN2 | |
| SCHEMBL23948594 | 0.69 | OPRM1 (0.37) | OPRM1XPO1MEN1KMT2ALMNA | |
| SCHEMBL24802935 | 0.69 | — | — | |
| SCHEMBL30050881 | 0.67 | — | — | |
| SCHEMBL24801656 | 0.66 | OPRM1 (0.34) | OPRM1XPO1MEN1KMT2AALDH1A1 | |
| SCHEMBL30050431 | 0.63 | POLB (0.39) | OPRM1MEN1KMT2APOLBSMN1; SMN2 | |
| SCHEMBL12919612 | 0.63 | ATM (0.46) | OPRM1MEN1KMT2AALDH1A1POLB | |
| SCHEMBL31128660 | 0.62 | ADAMTS5 (0.36) | OPRM1KMT2APOLBSMN1; SMN2ATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240279159-A1 | HERBICIDAL ARYLCYCLOPENTENE CARBOXAMIDES | BASF SE (DE) | 2024-08-22 | — | — | US | disclosed |
| CN-117545745-A | Herbicidal arylcyclopentene carboxamides | 巴斯夫欧洲公司 | 2024-02-09 | — | — | CN | disclosed |
| WO-2022268563-A1 | HERBICIDAL ARYLCYCLOPENTENE CARBOXAMIDES | BASF SE (DE) | 2022-12-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240279159-A1 | HERBICIDAL ARYLCYCLOPENTENE CARBOXAMIDES | CBR3, CBR1, HDHD5 | OPRM1 836/4885XPO1 3392/4885MEN1 4817/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.